Endocrine dysfunction and rehabilitation in maintenance hemodialysis patients

doi:10.3877/cma.j.issn.2095-3216.2021.06.008

Abstract

Abstract:

Maintenance hemodialysis (MHD) patients may have various dysfunction with the extension of dialysis age. Endocrine dysfunction is one of them, and can lead to abnormal glucose metabolism, abnormal thyroid function, abnormal parathyroid function, abnormal secretion of erythropoietin, abnormal gastrin secretion, and abnormal hypothalamic-pituitary-gonadal axis function, etc. Rehabilitation therapy can improve the endocrine disorders of MHD patients and improve their quality of life to a certain extent. This paper reviewed the main manifestations and rehabilitation strategies of endocrine dysfunction in MHD patients.

Key words: Hemodialysis, Endocrine dysfunction, Rehabilitation

Lan Zhang, Yingchun Ma. Endocrine dysfunction and rehabilitation in maintenance hemodialysis patients[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2021, 10(06): 337-341.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2021.06.008

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2021/V10/I06/337

References 40

[1]	Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glucose to type 2 diabetes [J]. Diabetes Care, 2007, 30(2): 228-233.
[2]	Young DO, Lund RJ, Haynatzki G, et al. Prevalence of the metabolic syndrome in an incident dialysis population [J]. Hemodial Int, 2007, 11(1): 86-95.
[3]	Razeghi E, Heydarian P, Heydari M. The frequency of prediabetes and contributing factors in patients with chronic kidney disease [J]. Rev Diabet Stud, 2011, 8(2): 276-281.
[4]	刘玉清. 血液透析中的低血糖及其防治[J]. 医学理论与实践. 2006，19(6):665-666.
[5]	任妍. 血液透析对终末期糖尿病肾病患者血糖的影响分析及干预研究[J/CD]. 中国医学前沿杂志(电子版). 2014(7): 124-127.
[6]	Rhee CM, Kalantar-Zadeh K, Streja E, et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease [J]. Nephrol Dial Transplant, 2015, 30(2): 282-287.
[7]	Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality [J]. JAMA, 2010, 304(12): 1365-1374.
[8]	Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study [J]. Clin J Am Soc Nephrol, 2015, 10(1): 98-109.
[9]	北京市血液透析登记2012年年度报告[J]. 中国血液净化. 2012, 11(z1): 前插1.
[10]	Malberti F, Marcelli D, Conte F, et al. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study [J]. J Am Soc Nephrol, 2001, 12(6): 1242-1248.
[11]	Zuo L, Wang M, Hou F, et al. Anemia management in the China dialysis outcomes and practice patterns study [J]. Blood Purif, 2016, 42(1): 33-43.
[12]	Ni Z, Jin H, Jiang G, et al. A telemedicine-based registration system for the management of renal anemia in patients on maintenance hemodialysis: multicenter study [J]. J Med Internet Res, 2019, 21(5): e13168.
[13]	Inaba M, Hayashino Y, Shoji T, et al. Disappearance of association in diabetic patients on hemodialysis between anemia and mortality risk: the Japan dialysis outcomes and practice pattern study [J]. Nephron Clin Pract, 2012, 120(2): c91-c100.
[14]	Kuragano T, Matsumura O, Matsuda A, et al. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients [J]. Kidney Int, 2014, 86(4): 845-854.
[15]	朱颖辉，李国刚. 维持性血液透析患者并发消化道出血28例临床分析[J]. 中国基层医药，2016, 23(13): 2031-2034.
[16]	卢慧，张敏，张家庆，等. 胃蛋白酶原水平与血液透析并发上消化道出血的关系研究[J]. 安徽医学. 2019, 40(2): 137-140.
[17]	Gungor O, Kircelli F, Carrero JJ, et al. Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging? [J]. Clin J Am Soc Nephrol, 2010, 5(11): 2018-2023.
[18]	Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group, Vecchio M, Palmer S, et al. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study [J]. Nephrol Dial Transplant, 2012, 27(6): 2479-2488.
[19]	Carrero JJ, Barany P, Yilmaz MI, et al. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease [J]. Nephrol Dial Transplant, 2012, 27(2): 709-715.
[20]	中国医师协会肾脏病医师分会血液透析充分性协作组. 中国血液透析充分性临床实践指南[J]. 中华医学杂志，2015, 95(34): 2748-2753.
[21]	中国医师协会内分泌代谢科医师分会. 2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识(2019年更新版)[J]. 中华内分泌代谢杂志，2019, 35(6): 447-454.
[22]	杨文英，陈璐璐，谌贻璞，等. 关于2型糖尿病合并慢性肾脏病患者应用胰岛素治疗的专家指导建议[J]. 中国糖尿病杂志. 2017, 25(10):865-868.
[23]	覃丹平，周道远，胡建广，等. 透析中输注高张葡萄糖液对血液透析患者血清氨基酸谱的影响[J]. 中国血液净化，2016，15(1): 22-25.
[24]	Velayeti J, Mansourian AR, Mojerloo M, et al. Evaluation of oxidative stress and thyroid hormone status in hemodialysis patients in Gorgan [J]. Indian J Endocrinol Metab, 2016, 20(3): 348-353.
[25]	中华医学会肾脏病学分会肾性贫血诊断和治疗共识专家组. 肾性贫血诊断与治疗中国专家共识(2018修订版)[J]. 中华肾脏病杂志，2018, 34(11): 860-866.
[26]	Ganz T, Aronoff GR, Gaillard C, et al. Iron administration, infection, and anemia management in CKD: untangling the effects of intravenous iron therapy on immunity and infection risk [J]. Kidney Med, 2020, 2(3): 341-353.
[27]	Chen N, Hao C, Liu BC, et al. Roxadustat treatment for anemia in patients undergoing long-term dialysis [J]. N Engl J Med, 2019, 381(11): 1011-1022.
[28]	畅飞，安军民，张莉，等. 奥美拉唑预防尿毒症血液透析患者上消化道出血的临床观察[J]. 海南医学，2013, 24(20): 3049-3050.
[29]	Canguven O, Aykose G, Albayrak S, et al. Efficacy of testosterone gel in the treatment of erectile dysfunction in hypogonadal hemodialysis patients: a pilot study [J]. Int J Impot Res, 2010, 22(2): 140-145.
[30]	Bao Y, Johansen KL. Diagnosis and treatment of low testosterone among patients with end-stage renal disease [J]. Semin Dial, 2015, 28(3): 259-265.
[31]	中国医师协会康复医师分会肾康复专业委员会，马迎春. 我国成人慢性肾脏病患者运动康复的专家共识[J]. 中华肾脏病杂志，2019, 35(7): 537-543.
[32]	程艳娇，韩玮，宋桂芸，等. 透析中的卧位体操对维持性血液透析患者的影响[J]. 中华肾脏病杂志，2015, 31(8): 583-588.
[33]	高德，朱文龙，祖静，等. 血液透析患者焦虑抑郁状态与营养不良相关性研究[J]. 人民军医，2014, 57(4): 406-407.
[34]	张兰，孙超，程艳娇，等. 维持性血液透析患者心理和认知功能调查及其影响因素分析[J]. 中国血液净化，2019, 18(2): 107-109.
[35]	Hou Y, Hu P, Liang Y, et al. Effects of cognitive behavioral therapy on insomnia of maintenance hemodialysis patients [J]. Cell Biochem Biophys, 2014, 69(3): 531-537.
[36]	Kim Y, Evangelista LS, Park YG. Anxiolytic effects of music interventions in patients receiving incenter hemodialysis: a systematic review and meta-analysis [J]. Nephrol Nurs J, 2015, 42(4): 339-347.
[37]	Lopes AA, Lantz B, Morgenstern H, et al. Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS [J]. Clin J Am Soc Nephrol, 2014, 9(10): 1702-1712.
[38]	王欣欣，孙超，崔家祯，等. 透析中递增式抗阻运动改善维持性血液透析(MHD)患者的心肺耐力、心理状态和健康相关生活质量[J]. 中国血液净化，2014，13(5): 390-393.
[39]	Reynolds JT, Homel P, Cantey L, et al. A one-year trial of in-center daily hemodialysis with an emphasis on quality of life [J]. Blood Purif, 2004, 22(3): 320-328.
[40]	Wang SY, Zang XY, Liu JD, et al. Indicators and correlates of psychological disturbance in Chinese patients receiving maintenance hemodialysis: a cross-sectional study [J]. Int Urol Nephrol, 2015, 47(4): 679-689.

Please choose a citation manager

Content to export